BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16638707)

  • 1. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
    Conn HO; Rössle M; Levy L; Glocker FX
    Scand J Gastroenterol; 2006 May; 41(5):619-25. PubMed ID: 16638707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portosystemic myelopathy: a rare neurological presentation of portosystemic shunts.
    Rao PK; Sheth KA; Nadig R; Patil M; Channagiri AK
    J Clin Exp Hepatol; 2012 Dec; 2(4):393-5. PubMed ID: 25755460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?
    Pinarbasi B; Kaymakoglu S; Matur Z; Akyuz F; Demir K; Besisik F; Ozdil S; Boztas G; Cakaloglu Y; Mungan Z; Okten A
    J Clin Gastroenterol; 2009 Feb; 43(2):176-81. PubMed ID: 18698265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation.
    Orug T; Soonawalla ZF; Tekin K; Olliff SP; Buckels JA; Mayer AD
    Br J Surg; 2004 Jun; 91(6):769-73. PubMed ID: 15164449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic myelopathy: a rare complication following extrahepatic portal vein occlusion and lienorenal shunt.
    Panicker J; Sinha S; Taly AB; Ravishankar S; Arunodaya GR
    Neurol India; 2006 Sep; 54(3):298-300. PubMed ID: 16936395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recanalized Paraumbilical Vein Leading to Hepatic Myelopathy Causing Spastic Paraparesis in a Patient with Chronic Liver Disease.
    Mundhra S; Mohta S; Gamanagatti S; Sharma S; Hemachandran N; Saraya A
    J Clin Exp Hepatol; 2023; 13(2):372-376. PubMed ID: 36950497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation: report of four cases.
    Wang MQ; Dake MD; Cui ZP; Wang ZQ; Gao YA
    J Vasc Interv Radiol; 2001 Jul; 12(7):879-81. PubMed ID: 11435545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic myelopathy after splenorenal shunting: report of one case and review of the literature.
    Yengue P; Adler M; Bouhdid H; Mavroudakis N; Gelin M; Bourgeois N
    Acta Gastroenterol Belg; 2001; 64(2):231-3. PubMed ID: 11475143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portosystemic encephalopathy in a patient treated with peritoneal dialysis.
    Paraíso V; Francos M; Rodríguez-Berzosa F; Felipe C; López-Valdés E; Martín R; Blázquez J; Chacón C; Fidalgo A; Martín J
    Am J Kidney Dis; 2007 Jun; 49(6):854-8. PubMed ID: 17533029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
    Kavitt RT; Yang VL; Jensen DM
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of portosystemic shunt surgery in the management of hepatic venous outflow obstruction.
    Singhal D; de Castro S; Goyal N; Gouma DJ; Chaudhary A; van Gulik TM
    Dig Surg; 2006; 23(5-6):358-69. PubMed ID: 17164547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome.
    Bachet JB; Condat B; Hagège H; Plessier A; Consigny Y; Belghiti J; Valla D
    J Hepatol; 2007 Jan; 46(1):60-8. PubMed ID: 17107735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trouble with a shunt: alcohol and spastic paraparesis. Hepatic myelopathy.
    O'Brien J; Staples C; Florin T
    Gastroenterology; 2010 Oct; 139(4):1099, 1428. PubMed ID: 20800654
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.
    Koo JE; Lim YS; Myung SJ; Suh KS; Kim KM; Lee HC; Chung YH; Lee YS; Suh DJ
    Korean J Hepatol; 2008 Mar; 14(1):89-96. PubMed ID: 18367861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital portosystemic shunt. The Abernethy malformation].
    Avila LF; Luis AL; Encinas JL; Hernández F; Olivares P; Fernández Cuadrado J; Hierro L; Jara P; López Santamaría M; Tovar JA
    Cir Pediatr; 2006 Oct; 19(4):204-9. PubMed ID: 17352108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
    Dell'Era A; Grande L; Barros-Schelotto P; Turnes J; Fuster J; Charco R; García-Valdecasas JC; Bosch J; García-Pagán JC
    Surgery; 2005 Jun; 137(6):620-5. PubMed ID: 15933628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic myelopathy with spastic paraparesis.
    Utku U; Asil T; Balci K; Uzunca I; Celik Y
    Clin Neurol Neurosurg; 2005 Oct; 107(6):514-6. PubMed ID: 16202825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic disconnection of a huge paraumbilical vein shunt for portosystemic encephalopathy.
    Yamaguchi S; Kawanaka H; Konishi K; Anegawa G; Yoshida D; Kinjo N; Tomikawa M; Hashizume M; Maehara Y
    Surg Laparosc Endosc Percutan Tech; 2007 Jun; 17(3):212-4. PubMed ID: 17581471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.